J.P. Morgan Private Wealth Advisors LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 113 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 3.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$163,000
+1.2%
62,6000.0%0.00%0.0%
Q1 2019$161,000
+11.8%
62,6000.0%0.00%0.0%
Q4 2018$144,000
-35.4%
62,600
-10.0%
0.00%0.0%
Q3 2018$223,000
+13.2%
69,5700.0%0.00%0.0%
Q2 2018$197,000
+6.5%
69,570
+32.8%
0.00%0.0%
Q1 2018$185,000
-8.9%
52,3700.0%0.00%0.0%
Q4 2017$203,000
+52.6%
52,3700.0%0.00%0.0%
Q3 2017$133,000
-7.0%
52,3700.0%0.00%0.0%
Q2 2017$143,000
-14.4%
52,370
+3.9%
0.00%0.0%
Q1 2017$167,000
+39.2%
50,400
-0.2%
0.00%0.0%
Q4 2016$120,000
-39.7%
50,500
-6.8%
0.00%
-50.0%
Q3 2016$199,000
+89.5%
54,193
+15.1%
0.00%
+100.0%
Q2 2016$105,000
+7.1%
47,1000.0%0.00%0.0%
Q1 2016$98,000
-31.5%
47,1000.0%0.00%0.0%
Q4 2015$143,000
+23.3%
47,1000.0%0.00%0.0%
Q3 2015$116,000
-24.2%
47,100
-1.1%
0.00%
-50.0%
Q2 2015$153,000
-10.0%
47,6000.0%0.00%0.0%
Q1 2015$170,00047,6000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders